The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Furfaro, A L ^a   Traverso, N ^b   Domenicotti, C ^b   Piras, S ^b   Moretta, L ^c   Marinari, U M ^b   Pronzato, M A ^b   Nitti, M ^b  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; DIAGNOSIS; TRANSCRIPTION FACTORS; TUMORS;

ANTICANCER TREATMENT; CANCER CELL GROWTH; CONFORMATIONAL CHANGE; HEME OXYGENASE-1; INHIBITORY PROTEINS; NUCLEAR TRANSLOCATIONS; RESPONSE ELEMENTS; TUMOUR PROGRESSION;

TRANSCRIPTION;

ANTINEOPLASTIC AGENT; HEME OXYGENASE 1; KELCH LIKE ECH ASSOCIATED PROTEIN 1; PROTEASOME; TRANSCRIPTION FACTOR NRF2; HMOX1 PROTEIN, HUMAN; NFE2L2 PROTEIN, HUMAN; TUMOR PROTEIN;

AUTOPHAGY; CANCER CELL; CANCER GROWTH; CANCER RESISTANCE; CHEMOPROPHYLAXIS; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME REGULATION; HUMAN; HUMAN CELL; MODULATION; MOLECULARLY TARGETED THERAPY; NEOPLASM; NONHUMAN; ONCOLOGY; PROTEIN STRUCTURE; REVIEW; STRESS; TRANSCRIPTION REGULATION; UBIQUITINATION; UPREGULATION; ANIMAL; DRUG RESISTANCE; METABOLISM; NEOPLASMS; SIGNAL TRANSDUCTION;

ANIMALS; DRUG RESISTANCE, NEOPLASM; HEME OXYGENASE-1; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; NF-E2-RELATED FACTOR 2; SIGNAL TRANSDUCTION;

EID: 84949883207     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/1958174     Document Type: Review

References (194)

1. S. C. Gupta, D. Hevia, S. Patchva, B. Park, W. Koh, and B. B. Aggarwal,"Upsides and downsides of reactive oxygen species for Cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy, "Antioxidants and Redox Signaling, vol. 16, no. 11, pp. 1295-1322, 2012
2. T. Ishii, K. Itoh, S. Takahashi et al. ,"Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes inmacrophages, "Journal of Biological Chemistry, vol. 275, no. 21, pp. 16023-16029, 2000
3. T. Ishii, K. Itoh, E. Ruiz et al. ,"Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidativelymodified LDL and 4-hydroxynonenal, "Circulation Research, vol. 94, no. 5, pp. 609-616, 2004
4. K. Itoh, J. Mimura, and M. Yamamoto,"Discovery of the negative regulator ofNrf2, keap1: a historical overview, "Antioxidants and Redox Signaling, vol. 13, no. 11, pp. 1665-1678, 2010
5. F. Weinberg and N. S. Chandel,"Reactive oxygen speciesdependent signaling regulates cancer, "Cellular and Molecular Life Sciences, vol. 66, no. 23, pp. 3663-3673, 2009
6. J. D. Hayes and M. McMahon,"NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer, "Trends in Biochemical Sciences, vol. 34, no. 4, pp. 176-188, 2009
7. K. Taguchi, H. Motohashi, and M. Yamamoto,"Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution, "Genes to Cells, vol. 16, no. 2, pp. 123-140, 2011
8. N. Traverso, R. Ricciarelli, M. Nitti et al. ,"Role of glutathione in cancer progression and chemoresistance, "OxidativeMedicine and Cellular Longevity, vol. 2013, Article ID 972913, 10 pages, 2013
9. H. Kumar, I.-S. Kim, S. V. More, B.-W. Kim, and D.-K. Choi,"Natural product-derived pharmacologicalmodulators ofNrf2/ARE pathway for chronic diseases, "Natural Product Reports, vol. 31, no. 1, pp. 109-139, 2014
10. D. Malhotra, E. Portales-Casamar, A. Singh et al. ,"Globalmapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis, "Nucleic Acids Research, vol. 38, no. 17, Article ID gkq212, pp. 5718-5734, 2010
11. B. N. Chorley, M. R. Campbell, X. Wang et al. ,"Identification of novel NRF2-regulated genes by ChiP-Seq: influence on retinoid X receptor alpha, "Nucleic Acids Research, vol. 40, no. 15, pp. 7416-7429, 2012
12. J. D. Hayes and A. T. Dinkova-Kostova,"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism, "Trends in Biochemical Sciences, vol. 39, no. 4, pp. 199-218, 2014
13. P. Moi, K. Chan, I. Asunis, A. Cao, and Y. W. Kan,"Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region, "Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 21, pp. 9926-9930, 1994
14. M. C. Jaramillo and D. D. Zhang,"The emerging role of the Nrf2-Keap1 signaling pathway in cancer, "Genes and Development, vol. 27, no. 20, pp. 2179-2191, 2013
15. E. J. Moon and A. Giaccia,"Dual roles of NRF2 in tumor prevention and progression: possible implications in cancer treatment, "Free Radical Biology and Medicine, vol. 79, pp. 292-299, 2015
16. Y. Hirotsu, F. Katsuoka, R. Funayama et al. ,"Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks, "Nucleic Acids Research, vol. 40, no. 20, pp. 10228-10239, 2012
17. K. I. Tong, Y. Katoh, H. Kusunoki, K. Itoh, T. Tanaka, and M. Yamamoto,"Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model, "Molecular and Cellular Biology, vol. 26, no. 8, pp. 2887-2900, 2006
18. J.-H. Kim, S. Yu, J. D. Chen, andA. N. Kong,"The nuclear cofactor RAC3/AIB1/SRC-3 enhances Nrf2 signaling by interacting with transactivation domains, "Oncogene, vol. 32, no. 4, pp. 514-527, 2013
19. P. Rada, A. I. Rojo, S. Chowdhry, M. McMahon, J. D. Hayes, and A. Cuadrado,"SCF/-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner, "Molecular and Cellular Biology, vol. 31, no. 6, pp. 1121-1133, 2011
20. H. Wang, K. Liu, M. Geng et al. ,"RXR inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2, "Cancer Research, vol. 73, no. 10, pp. 3097-3108, 2013
21. S. B. Cullinan, J. D. Gordan, J. Jin, J. W. Harper, and J. A. Diehl,"The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase, "Molecular and Cellular Biology, vol. 24, no. 19, pp. 8477-8486, 2004
22. A. Kobayashi, M.-I. Kang, H. Okawa et al. ,"Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2, "Molecular and Cellular Biology, vol. 24, no. 16, pp. 7130-7139, 2004
23. A. Kobayashi, M.-I. Kang, Y. Watai et al. ,"Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity ofKeap1, "Molecular and Cellular Biology, vol. 26, no. 1, pp. 221-229, 2006
24. W. O. Osburn and T. W. Kensler,"Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults, "Mutation Research-Reviews in Mutation Research, vol. 659, no. 1-2, pp. 31-39, 2008
25. K. Itoh, N. Wakabayashi, Y. Katoh et al. ,"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain, "Genes &Development, vol. 13, no. 1, pp. 76-86, 1999
26. R. Holland and J. C. Fishbein,"Chemistry of the cysteine sensors in kelch-like ECH-Associated protein 1, "Antioxidants and Redox Signaling, vol. 13, no. 11, pp. 1749-1761, 2010
27. T. Yamamoto, T. Suzuki, A. Kobayashi et al. ,"Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity, "Molecular and Cellular Biology, vol. 28, no. 8, pp. 2758-2770, 2008
28. A. T. Dinkova-Kostova, W. D. Holtzclaw, R. N. Cole et al. ,"Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants, "Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 18, pp. 11908-11913, 2002
29. N. Wakabayashi, A. T. Dinkova-Kostova, W. D. Holtzclaw et al. ,"Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers, "Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 7, pp. 2040-2045, 2004
30. K. Takaya, T. Suzuki, H. Motohashi et al. ,"Validation of the multiple sensor mechanism of the Keap1-Nrf2 system, "Free Radical Biology and Medicine, vol. 53, no. 4, pp. 817-827, 2012
31. H. K. Bryan, A. Olayanju, C. E. Goldring, and B. K. Park,"The Nrf2 cell defence pathway: Keap1-dependent and-independent mechanisms of regulation, "Biochemical Pharmacology, vol. 85, no. 6, pp. 705-717, 2013
32. M. Kobayashi, L. Li, N. Iwamoto et al. ,"The antioxidant defense systemKeap1-Nrf2 comprises amultiple sensingmechanism for responding to a wide range of chemical compounds, "Molecular and Cellular Biology, vol. 29, no. 2, pp. 493-502, 2009
33. M. Komatsu, H. Kurokawa, S. Waguri et al. ,"The selective autophagy substrate p62 activates the stress responsive transcription factorNrf2 through inactivation of Keap1, "Nature Cell Biology, vol. 12, no. 3, pp. 213-223, 2010
34. Y. Ichimura, S. Waguri, Y.-S. Sou et al. ,"Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy, "Molecular Cell, vol. 51, no. 5, pp. 618-631, 2013
35. K. Taguchi, N. Fujikawa, M. Komatsu et al. ,"Keap1 degradation by autophagy for the maintenance of redox homeostasis, "Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 34, pp. 13561-13566, 2012
36. T. Wu, F. Zhao, B. Gao et al. ,"Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis, "Genes and Development, vol. 28, no. 7, pp. 708-722, 2014
37. S. Chowdhry, Y. Zhang, M. McMahon, C. Sutherland, A. Cuadrado, and J. D. Hayes,"Nrf2 is controlled by two distinct beta-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity, "Oncogene, vol. 32, no. 32, pp. 3765-3781, 2013
38. S. Tao, S. Wang, S. J. Moghaddamet al. ,"Oncogenic KRAS confers chemoresistance by upregulating NRF2, "Cancer Research, vol. 74, no. 24, pp. 7430-7441, 2014
39. G. M. Denicola, F. A. Karreth, T. J. Humpton et al. ,"Oncogeneinduced Nrf2 transcription promotes ROS detoxification and tumorigenesis, "Nature, vol. 475, no. 7354, pp. 106-109, 2011
40. M. Ramos-Gomez, M.-K. Kwak, P. M. Dolan et al. ,"Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice, "Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 6, pp. 3410-3415, 2001
41. K. Iida, K. Itoh, Y. Kumagai et al. ,"Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis, "Cancer Research, vol. 64, no. 18, pp. 6424-6431, 2004
42. C. Xu, M.-T. Huang, G. Shen et al. ,"Inhibition of 7, 12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2, "Cancer Research, vol. 66, no. 16, pp. 8293-8296, 2006
43. T. O. Khor, M.-T. Huang, A. Prawan et al. ,"Increased susceptibility of Nrf2 knockout mice to colitis-Associated colorectal cancer, "Cancer Prevention Research, vol. 1, no. 3, pp. 187-191, 2008
44. L. Becks, M. Prince, H. Burson et al. ,"Aggressive mammary carcinoma progression inNrf2 knockout mice treated with 7, 12-dimethylbenz[a]anthracene, "BMC Cancer, vol. 10, article 540, 2010
45. T. Yamamoto, K. Yoh, A. Kobayashi et al. ,"Identification of polymorphisms in the promoter region of the human NRF2 gene, "Biochemical and Biophysical Research Communications, vol. 321, no. 1, pp. 72-79, 2004
46. T. Suzuki, T. Shibata, K. Takaya et al. ,"Regulatory nexus of synthesis and degradation deciphers cellular Nrf2 expression levels, "Molecular and Cellular Biology, vol. 33, no. 12, pp. 2402-2412, 2013
47. X.-J. Wang, Z. Sun, N. F. Villeneuve et al. ,"Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2, "Carcinogenesis, vol. 29, no. 6, pp. 1235-1243, 2008
48. H.-K. Na and Y.-J. Surh,"Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1, "Free Radical Biology and Medicine, vol. 67, pp. 353-365, 2014
49. T. Shibata, T. Ohta, K. I. Tong et al. ,"Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy, "Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 36, pp. 13568-13573, 2008
50. D. D. Zhang,"Mechanistic studies of the Nrf2-Keap1 signaling pathway, "DrugMetabolism Reviews, vol. 38, no. 4, pp. 769-789, 2006
51. P. Nioi and T. Nguyen,"A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity, "Biochemical and Biophysical Research Communications, vol. 362, no. 4, pp. 816-821, 2007
52. D. R. Stacy, K. Ely, P. P. Massion et al. ,"Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas, "Head and Neck, vol. 28, no. 9, pp. 813-818, 2006
53. M. G. P. van der Wijst, R. Brown, and M. G. Rots,"Nrf2, the master redox switch: the Achilles' heel of ovarian cancer"Biochimica et BiophysicaActa-Reviews onCancer, vol. 1846, no. 2, pp. 494-509, 2014
54. T. Jiang, N. Chen, F. Zhao et al. ,"High levels of Nrf2 determine chemoresistance in type II endometrial cancer, "Cancer Research, vol. 70, no. 13, pp. 5486-5496, 2010
55. Y. Mitsuishi, H. Motohashi, and M. Yamamoto,"The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism, "Frontiers in Oncology, vol. 2, article 200, 2012
56. T. Shibata, S. Saito, A. Kokubu, T. Suzuki, M. Yamamoto, and S. Hirohashi,"Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway, "Cancer Research, vol. 70, no. 22, pp. 9095-9105, 2010
57. P. Shelton and A. K. Jaiswal,"The transcription factor NF-E2-related factor 2 (nrf2): a protooncogene"The FASEB Journal, vol. 27, no. 2, pp. 414-423, 2013
58. L. A. Muscarella, P. Parrella, V. D'Alessandro et al. ,"Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer, "Epigenetics, vol. 6, no. 6, pp. 710-719, 2011
59. P. Zhang, A. Singh, S. Yegnasubramanian et al. ,"Loss of kelch-like ECH-Associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth, "Molecular CancerTherapeutics, vol. 9, no. 2, pp. 336-346, 2010
60. N. Hanada, T. Takahata, Q. Zhou et al. ,"Methylation of the KEAP1 gene promoter region in human colorectal cancer, "BMC Cancer, vol. 12, article 66, 2012
61. A. Ooi, K. Dykema, A. Ansari et al. ,"CUL3 and NRF2mutations confer an NRF2 activation phenotype in a sporadic form of papillary renal cell carcinoma, "Cancer Research, vol. 73, no. 7, pp. 2044-2051, 2013
62. M. Loignon, W. Miao, L. Hu et al. ,"Cul3 overexpression depletes Nrf2 in breast cancer and is associated with sensitivity to carcinogens, to oxidative stress, and to chemotherapy, "Molecular CancerTherapeutics, vol. 8, no. 8, pp. 2432-2440, 2009
63. V. D. Martinez, E. A. Vucic, K. L. Thu, L. A. Pikor, S. Lam, and W. L. Lam,"Disruption of KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex components by multiple genetic mechanisms: association with poor prognosis in head and neck cancer, "Head and Neck, vol. 37, no. 5, pp. 727-734, 2015
64. V. D. Martinez, E. A. Vucic, K. L. Thu, L. A. Pikor, R. Hubaux, andW. L. Lam,"Unique pattern of component gene disruption in the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in serous ovarian cancer, "BioMed Research International, vol. 2014, Article ID 159459, 10 pages, 2014
65. V. D. Martinez, E. A. Vucic, L. A. Pikor, K. L. Thu, R. Hubaux, and W. L. Lam,"Frequent concerted genetic mechanisms disrupt multiple components of the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in thyroid cancer, "Molecular Cancer, vol. 12, no. 1, article 124, 2013
66. N. F. Villeneuve, Z. Sun, W. Chen, and D. D. Zhang,"Nrf2 and p21 regulate the fine balance between life and death by controlling ROS levels, "Cell Cycle, vol. 8, no. 20, pp. 3255-3256, 2009
67. W. Chen, Z. Sun, X.-J. Wang et al. ,"Direct interaction between Nrf2 and p21Cip1/WAF1 upregulates the Nrf2-mediated antioxidant response, "Molecular Cell, vol. 34, no. 6, pp. 663-673, 2009
68. C. M. Clements, R. S. McNally, B. J. Conti, T. W. Mak, and J. P.-Y. Ting,"DJ-1, a cancer-And Parkinson's disease-Associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2, "Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 41, pp. 15091-15096, 2006
69. L. Gan, D. A. Johnson, and J. A. Johnson,"Keap1-Nrf2 activation in the presence and absence of DJ-1, "European Journal of Neuroscience, vol. 31, no. 6, pp. 967-977, 2010
70. J. P. MacKeigan, C. M. Clements, J. D. Lich, R. M. Pope, Y. Hod, and J. P.-Y. Ting,"Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha, "Cancer Research, vol. 63, no. 20, pp. 6928-6934, 2003
71. T. Taira, Y. Saito, T. Niki, S. M. M. Iguchi-Ariga, K. Takahashi, and H. Ariga,"DJ-1 has a role in antioxidative stress to prevent cell death, "The EMBO Reports, vol. 5, no. 2, pp. 213-218, 2004
72. I. M. Copple, A. Lister, A. D. Obeng et al. ,"Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway, "The Journal of Biological Chemistry, vol. 285, no. 22, pp. 16782-16788, 2010
73. A. Jain, T. Lamark, E. Sjottem et al. ,"p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription, "Journal of Biological Chemistry, vol. 285, no. 29, pp. 22576-22591, 2010
74. N. D. Camp, R. G. James, D. W. Dawson et al. ,"Wilms tumor gene on X chromosome (WTX) inhibits degradation of NRF2 protein through competitive binding toKEAP1 protein, "Journal of Biological Chemistry, vol. 287, no. 9, pp. 6539-6550, 2012
75. J. Ma, H. Cai, T. Wu et al. ,"PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function, "Molecular and Cellular Biology, vol. 32, no. 8, pp. 1506-1517, 2012
76. B. E. Hast, D. Goldfarb, K. M. Mulvaney et al. ,"Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination, "Cancer Research, vol. 73, no. 7, pp. 2199-2210, 2013
77. N. Wakabayashi, S. Shin, S. L. Slocum et al. ,"Regulation of Notch1 signaling by Nrf2: implications for tissue regeneration, "Science Signaling, vol. 3, no. 130, article ra52, 2010
78. A. You, C.-W. Nam, N. Wakabayashi, M. Yamamoto, T. W. Kensler, andM.-K. Kwak,"Transcription factor Nrf2 maintains the basal expression of Mdm2: an implication of the regulation of p53 signaling by Nrf2, "Archives of Biochemistry and Biophysics, vol. 507, no. 2, pp. 356-364, 2011
79. J. Wang, M. Zhang, L. Zhang et al. ,"Correlation of Nrf2, HO-1, and MRP3 in gallbladder cancer and their relationships to clinicopathologic features and survival, "Journal of Surgical Research, vol. 164, no. 1, pp. e99-e105, 2010
80. W. D. Kim, Y. W. Kim, I. J. Cho, C. H. Lee, and S. G. Kim,"Ecadherin inhibits nuclear accumulation of Nrf2: implications for chemoresistance of cancer cells, "Journal of Cell Science, vol. 125, no. 5, pp. 1284-1295, 2012
81. A. K. Jain, D. A. Bloom, and A. K. Jaiswal,"Nuclear import and export signals in control of Nrf2, "The Journal of Biological Chemistry, vol. 280, no. 32, pp. 29158-29168, 2005
82. H. Shen, Y. Yang, S. Xia, B. Rao, J. Zhang, and J. Wang,"Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment, "Diseases of the Esophagus, vol. 27, no. 7, pp. 685-692, 2014
83. G. L. Semenza,"Intratumoral hypoxia, radiation resistance, and HIF-1, "Cancer Cell, vol. 5, no. 5, pp. 405-406, 2004
84. T.-H. Kim, E.-G. Hur, S.-J. Kang et al. ,"NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxiainduced activation of HIF-1, "Cancer Research, vol. 71, no. 6, pp. 2260-2275, 2011
85. G.-S. Shim, S. Manandhar, D.-H. Shin, T.-H. Kim, and M.-K. Kwak,"Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway, "Free Radical Biology and Medicine, vol. 47, no. 11, pp. 1619-1631, 2009
86. Y. Zhong, F. Zhang, Z. Sun et al. ,"Drug resistance associates with activation of Nrf2 in MCF-7/DOX cells, and wogonin reverses it by down-regulating Nrf2-mediated cellular defense response, "Molecular Carcinogenesis, vol. 52, no. 10, pp. 824-834, 2013
87. S. Homma, Y. Ishii, Y. Morishima et al. ,"Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer, "Clinical Cancer Research, vol. 15, no. 10, pp. 3423-3432, 2009
88. S. Jayakumar, A. Kunwar, S. K. Sandur, B. N. Pandey, and R. C. Chaubey,"Differential response of DU145 and PC3 prostate cancer cells to ionizing radiation: role of reactive oxygen species, GSH and Nrf2 in radiosensitivity, "Biochimica et Biophysica Acta-General Subjects, vol. 1840, no. 1, pp. 485-494, 2014
89. S. Lee, M.-J. Lim, M.-H. Kim et al. ,"An effective strategy for increasing the radiosensitivity of Human lung Cancer cells by blocking Nrf2-dependent antioxidant responses, "Free Radical Biology and Medicine, vol. 53, no. 4, pp. 807-816, 2012
90. A. L. Furfaro, J. R. Z. MacAy, B. Marengo et al. ,"Resistance of neuroblastoma GI-ME-N cell line to glutathione depletion involves Nrf2 and heme oxygenase-1, "Free Radical Biology and Medicine, vol. 52, no. 2, pp. 488-496, 2012
91. A. L. Furfaro, S. Piras, M. Passalacqua et al. ,"HO-1 upregulation: a key point in high-risk neuroblastoma resistance to bortezomib, "Biochimica et Biophysica Acta, vol. 1842, no. 4, pp. 613-622, 2014
92. A. Singh, H. Wu, P. Zhang, C. Happel, J. Ma, and S. Biswal,"Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype, "Molecular Cancer Therapeutics, vol. 9, no. 8, pp. 2365-2376, 2010
93. C. Geismann, A. Arlt, S. Sebens, and H. Schafer,"Cytoprotection"gone astray": Nrf2 and its role in cancer, "OncoTargets and Therapy, vol. 7, pp. 1497-1518, 2014
94. C. M. Mahaffey, H. Zhang, A. Rinna, W. Holland, P. C. Mack, and H. J. Forman,"Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma, "Free Radical Biology and Medicine, vol. 46, no. 12, pp. 1650-1657, 2009
95. S. L. Slocum and T. W. Kensler,"Nrf2: control of sensitivity to carcinogens, "Archives of Toxicology, vol. 85, no. 4, pp. 273-284, 2011
96. J. J. Tsai, J. A. Dudakov, K. Takahashi et al. ,"Nrf2 regulates haematopoietic stem cell function, "Nature Cell Biology, vol. 15, no. 3, pp. 309-316, 2013
97. D. M. Santos, M. M. M. Santos, R. Moreira, S. Soĺa, and C. M. P. Rodrigues,"Synthetic condensed 1, 4-naphthoquinone derivative shifts neural stem cell differentiation by regulating redox state, "Molecular Neurobiology, vol. 47, no. 1, pp. 313-324, 2013
98. S. Murakami and H. Motohashi,"Roles of NRF2 in cell proliferation and differentiation, "Free Radical Biology and Medicine, 2015
99. T.-C. A. Johannessen, R. Bjerkvig, and B. B. Tysnes,"DNA repair and cancer stem-like cells-potential partners in glioma drug resistance?"Cancer Treatment Reviews, vol. 34, no. 6, pp. 558-567, 2008
100. J. Zhu, H. Wang, Q. Sun et al. ,"Nrf2 is required to maintain the self-renewal of glioma stem cells, "BMC Cancer, vol. 13, article 380, 2013
101. J. Zhu, H. Wang, X. Ji et al. ,"Differential Nrf2 expression between glioma stem cells and non-stem-like cells in glioblastoma, "Oncology Letters, vol. 7, no. 3, pp. 693-698, 2014
102. T. Wu, B. G. Harder, P. K. Wong, J. E. Lang, and D. D. Zhang,"Oxidative stress, mammospheres and Nrf2-new implication for breast cancer therapy?"Molecular Carcinogenesis, 2014
103. G. M. Trakshel and M. D. Maines,"Multiplicity of heme oxygenase isozymes. HO-1 and HO-2 are different molecular species in rat and rabbit, "Journal of Biological Chemistry, vol. 264, no. 2, pp. 1323-1328, 1989
104. M. D. Maines,"Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications, "TheFASEB Journal, vol. 2, no. 10, pp. 2557-2568, 1988
105. S. W. Ryter andA. M. K. Choi,"Targetinghemeoxygenase-1 and carbonmonoxide for therapeuticmodulation of inflammation, "Translational Research, 2015
106. M. D. Maines, G. M. Trakshel, and R. K. Kutty,"Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible, "The Journal of Biological Chemistry, vol. 261, no. 1, pp. 411-419, 1986
107. J. Alam, S. Shibahara, and A. Smith,"Transcriptional activation of the heme oxygenase gene by heme and cadmium in mouse hepatoma cells, "Journal of Biological Chemistry, vol. 264, no. 11, pp. 6371-6375, 1989
108. S. M. Keyse andR. M. Tyrrell,"Heme oxygenase is themajor 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodiumarsenite, "Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 1, pp. 99-103, 1989
109. R. Foresti, J. E. Clark, C. J. Green, andR. Motterlini,"Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells: involvement of superoxide and peroxynitrite anions, "The Journal of Biological Chemistry, vol. 272, no. 29, pp. 18411-18417, 1997
110. C. M. Terry, J. A. Clikeman, J. R. Hoidal, and K. S. Callahan,"Effect of tumor necrosis factor-Alpha and interleukin-1 on heme oxygenase-1 expression in human endothelial cells, "American Journal of Physiology, vol. 274, no. 3, part 2, pp. H883-H891, 1998
111. R. Stocker, Y. Yamamoto, A. F. McDonagh, A. N. Glazer, and B. N. Ames,"Bilirubin is an antioxidant of possible physiological importance, "Science, vol. 235, no. 4792, pp. 1043-1046, 1987
112. S. Brouard, L. E. Otterbein, J. Anrather et al. ,"Carbonmonoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis, "Journal of Experimental Medicine, vol. 192, no. 7, pp. 1015-1026, 2000
113. R. J. Ward, S. Wilmet, R. Legssyer, and R. R. Crichton,"The influence of iron homoeostasis on macrophage function, "Biochemical Society Transactions, vol. 30, no. 4, pp. 762-765, 2002
114. S. W. Ryter and A. M. K. Choi,"Heme oxygenase-1: redox regulation of a stress protein in lung and cell culture models, "Antioxidants and Redox Signaling, vol. 7, no. 1-2, pp. 80-91, 2005
115. A. Prawan, J. K. Kundu, and Y.-J. Surh,"Molecular basis of heme oxygenase-1 induction: implications for chemoprevention and chemoprotection, "Antioxidants and Redox Signaling, vol. 7, no. 11-12, pp. 1688-1703, 2005
116. A. Jozkowicz, H. Was, and J. Dulak,"Heme oxygenase-1 in tumors: Is it a false friend?"Antioxidants and Redox Signaling, vol. 9, no. 12, pp. 2099-2117, 2007
117. P. Banerjee, A. Basu, D. Datta, M. Gasser, A. M. Waaga-Gasser, and S. Pal,"The heme oxygenase-1 protein is overexpressed in human renal cancer cells following activation of the Ras-Raf-ERK pathway and mediates anti-Apoptotic signal, "The Journal of Biological Chemistry, vol. 286, no. 38, pp. 33580-33590, 2011
118. H. Yin, J. Fang, L. Liao, H. Maeda, and Q. Su,"Upregulation of heme oxygenase-1 in colorectal cancer patients with increased circulation carbon monoxide levels, potentially affects chemotherapeutic sensitivity, "BMC Cancer, vol. 14, no. 1, article 436, 2014
119. P. O. Berberat, Z. Dambrauskas, A. Gulbinas et al. ,"Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment, "Clinical Cancer Research, vol. 11, no. 10, pp. 3790-3798, 2005
120. M. S. Degese, J. E. Mendizabal, N. A. Gandini et al. ,"Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data, "Lung Cancer, vol. 77, no. 1, pp. 168-175, 2012
121. M. Miyake, K. Fujimoto, S. Anai et al. ,"Clinical significance of heme oxygenase-1 expression in non-muscle-invasive bladder cancer, "Urologia Internationalis, vol. 85, no. 3, pp. 355-363, 2010
122. J.-R. Tsai, H.-M. Wang, P.-L. Liu et al. ,"High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients, "Cellular Oncology, vol. 35, no. 6, pp. 461-471, 2012
123. H. Was, T. Cichon, R. Smolarczyk et al. ,"Overexpression of heme oxygenase-1 inmurinemelanoma: increased proliferation and viability of tumor cells, decreased survival of mice, "The American Journal of Pathology, vol. 169, no. 6, pp. 2181-2198, 2006
124. M. Sunamura, D. G. Duda, M. H. Ghattas et al. ,"Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer, "Angiogenesis, vol. 6, no. 1, pp. 15-24, 2003
125. S.-S. Lee, S.-F. Yang, C.-H. Tsai, M.-C. Chou, M.-Y. Chou, and Y.-C. Chang,"Upregulation of heme oxygenase-1 expression in areca-quid-chewing-Associated oral squamous cell carcinoma, "Journal of the Formosan Medical Association, vol. 107, no. 5, pp. 355-363, 2008
126. M. A. Alaoui-Jamali, T. A. Bismar, A. Gupta et al. ,"A novel experimental heme oxygenase-1-targeted therapy for hormonerefractory prostate cancer, "Cancer Research, vol. 69, no. 20, pp. 8017-8024, 2009
127. G. Sass, P. Leukel, V. Schmitz et al. ,"Inhibition of heme oxygenase 1 expression by small interfering RNAdecreases orthotopic tumor growth in livers of mice, "International Journal of Cancer, vol. 123, no. 6, pp. 1269-1277, 2008
128. M. J. Marinissen, T. Tanos, M. Boĺos, M. R. De Sagarra, O. A. Coso, and A. Cuadrado,"Inhibition of heme oxygenase-1 interferes with the transforming activity of the Kaposi sarcoma herpesvirus-encoded G protein-coupled receptor, "The Journal of Biological Chemistry, vol. 281, no. 16, pp. 11332-11346, 2006
129. H. Was, J. Dulak, and A. Jozkowicz,"Heme oxygenase-1 in tumor biology and therapy, "Current Drug Targets, vol. 11, no. 12, pp. 1551-1570, 2010
130. A. Loboda, A. Jazwa, A. Grochot-Przeczek et al. ,"Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities, "Antioxidants &Redox Signaling, vol. 10, no. 10, pp. 1767-1812, 2008
131. J. Fang, K. Greish, H. Qin et al. ,"HSP32 (HO-1) inhibitor, copoly(styrene-maleic acid)-zinc protoporphyrin IX, a watersoluble micelle as anticancer agent: in vitro and in vivo anticancer effect, "European Journal of Pharmaceutics and Biopharmaceutics, vol. 81, no. 3, pp. 540-547, 2012
132. H. Nakamura, L. Liao, Y. Hitaka et al. ,"Micelles of zinc protoporphyrin conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer for imaging and light-induced antitumor effects in vivo, "Journal of Controlled Release, vol. 165, no. 3, pp. 191-198, 2013
133. P. Nuhn, B. M. Kunzli, R. Hennig et al. ,"Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo, "Molecular Cancer, vol. 8, article 37, 2009
134. W. Zhang, T. Qiao, and L. Zha,"Inhibition of heme oxygenase-1 enhances the radiosensitivity in human nonsmall cell lung cancer A549 cells, "Cancer Biotherapy and Radiopharmaceuticals, vol. 26, no. 5, pp. 639-645, 2011
135. D. Nowis, M. Legat, T. Grzela et al. ,"Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity, "Oncogene, vol. 25, no. 24, pp. 3365-3374, 2006
136. D. Ma, Q. Fang, P. Wang et al. ,"Induction of heme oxygenase-1 by Na+-H+ exchanger 1 protein plays a crucial role in imatinib-resistant chronic myeloid leukemia cells, "The Journal of Biological Chemistry, vol. 290, no. 20, pp. 12558-12571, 2015
137. W.-K. Jeon, H.-Y. Hong, W.-C. Seo et al. ,"Smad7 sensitizes A549 lung cancer cells to cisplatin-induced apoptosis through heme oxygenase-1 inhibition, "Biochemical and Biophysical Research Communications, vol. 420, no. 2, pp. 288-292, 2012
138. Y. Yin, Q. Liu, B. Wang, G. Chen, L. Xu, and H. Zhou,"Expression and function of heme oxygenase-1 in human gastric cancer, "Experimental Biology and Medicine, vol. 237, no. 4, pp. 362-371, 2012
139. M. Mayerhofer, S. Florian, M.-T. Krauth et al. ,"Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia, "Cancer Research, vol. 64, no. 9, pp. 3148-3154, 2004
140. M. Hill, V. Pereira, C. Chauveau et al. ,"Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2, 3-dioxygenase, "The FASEB Journal, vol. 19, no. 14, pp. 1957-1968, 2005
141. M. Ferrando, G. Gueron, B. Elguero et al. ,"Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer, "Angiogenesis, vol. 14, no. 4, pp. 467-479, 2011
142. C.-Y. Chao, C.-K. Lii, Y.-T. Hsu et al. ,"Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells, "Carcinogenesis, vol. 34, no. 8, pp. 1843-1851, 2013
143. B. Wegiel, Z. Nemeth, M. Correa-Costa, A. C. Bulmer, and L. E. Otterbein,"Heme oxygenase-1: a metabolic nike, "Antioxidants and Redox Signaling, vol. 20, no. 11, pp. 1709-1722, 2014
144. S. W. Ryter, S. Xi, C. L. Hartsfield, and A. M. K. Choi,"Mitogen activated protein kinase (MAPK) pathway regulates heme oxygenase-1 gene expression by hypoxia in vascular cells, "Antioxidants and Redox Signaling, vol. 4, no. 4, pp. 587-592, 2002
145. C.-C. Lin, L.-L. Chiang, C.-H. Lin et al. ,"Transforming growth factor-beta1 stimulates heme oxygenase-1 expression via the PI3K/Akt and NF-kappaB pathways in human lung epithelial cells, "European Journal of Pharmacology, vol. 560, no. 2-3, pp. 101-109, 2007
146. Y. Lavrovsky, M. L. Schwartzman, R. D. Levere, A. Kappas, and N. G. Abraham,"Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene, "Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 13, pp. 5987-5991, 1994
147. S. A. Rushworth, K. M. Bowles, P. Raninga, and D. J. MacEwan,"NF-B-Lnhibited acute myeloid leukemia cells are rescued from apoptosis by heme oxygenase-1 induction, "Cancer Research, vol. 70, no. 7, pp. 2973-2983, 2010
148. E. O. Farombi and Y.-J. Surh,"Heme oxygenase-1 as a potential therapeutic target for hepatoprotection, "Journal of Biochemistry and Molecular Biology, vol. 39, no. 5, pp. 479-491, 2006
149. L.-H. Wang, Y. Li, S.-N. Yang et al. ,"Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-smallcell lung cancer through suppressing NF-B andMAPK/HO-1 signalling, "British Journal of Cancer, vol. 110, no. 2, pp. 341-352, 2014
150. S. Nemmiche, D. Chabane-Sari, M. Kadri, and P. Guiraud,"Cadmium-induced apoptosis in the BJAB human B cell line: involvement of PKC/ERK1/2/JNK signaling pathways in HO-1 expression, "Toxicology, vol. 300, no. 3, pp. 103-111, 2012
151. P.-Y. Cheng, Y.-M. Lee, N.-L. Shih, Y.-C. Chen, and M.-H. Yen,"Heme oxygenase-1 contributes to the cytoprotection of alphalipoic acid via activation of p44/42 mitogen-Activated protein kinase in vascular smooth muscle cells, "Free Radical Biology and Medicine, vol. 40, no. 8, pp. 1313-1322, 2006
152. M. T. Do, H. G. Kim, T. Khanal et al. ,"Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways, "Toxicology and Applied Pharmacology, vol. 271, no. 2, pp. 229-238, 2013
153. L. N. Barrera, S. A. Rushworth, K. M. Bowles, and D. J. MacEwan,"Bortezomib induces heme oxygenase-1 expression in multiple myeloma, "Cell Cycle, vol. 11, no. 12, pp. 2248-2252, 2012
154. S. Bancos, C. J. Baglole, I. Rahman, andR. P. Phipps,"Induction of heme oxygenase-1 in normal and malignant B lymphocytes by 15-deoxy-12. 14-prostaglandin J2 requires Nrf2, "Cellular Immunology, vol. 262, no. 1, pp. 18-27, 2010
155. D.-Y. Lu, W.-L. Yeh, S.-M. Huang, C.-H. Tang, H.-Y. Lin, and S.-J. Chou,"Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells, "Neuro-Oncology, vol. 14, no. 11, pp. 1367-1378, 2012
156. L.-J. Bao, M. C. Jaramillo, Z.-B. Zhang et al. ,"Nrf2 induces cisplatin resistance through activation of autophagy in ovarian carcinoma, "International Journal of Clinical and Experimental Pathology, vol. 7, no. 4, pp. 1502-1513, 2014
157. T. W. Kensler, T. J. Curphey, Y. Maxiutenko, and B. D. Roebuck,"Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins, "Drug Metabolism and Drug Interactions, vol. 17, no. 1-4, pp. 3-22, 2000
158. C. C. Conaway, C.-X. Wang, B. Pittman et al. ,"Phenethyl isothiocyanate and sulforaphane and their N-Acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice, "Cancer Research, vol. 65, no. 18, pp. 8548-8557, 2005
159. R. Garg, S. Gupta, and G. B. Maru,"Dietary curcumin modulates transcriptional regulators of phase I and phase II enzymes in benzo[a]pyrene-treated mice: mechanism of its antiinitiating action, "Carcinogenesis, vol. 29, no. 5, pp. 1022-1032, 2008
160. R. K. Thimmulappa, T. Rangasamy, J. Alam, and S. Biswal,"Dibenzoylmethane activates Nrf2-dependent detoxification pathway and inhibits benzo(a)pyrene induced DNA adducts in lungs, "Medicinal Chemistry, vol. 4, no. 5, pp. 473-481, 2008
161. B. Singh, R. Shoulson, A. Chatterjee et al. ,"Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways, "Carcinogenesis, vol. 35, no. 8, pp. 1872-1880, 2014
162. K. M. Chang, F. P. Liang, I. L. Chen et al. ,"Discovery of oximebearing naphthalene derivatives as a novel structural type of Nrf2 activators, "Bioorganic &Medicinal Chemistry, vol. 23, no. 13, pp. 3852-3859, 2015
163. F.-F. Gan, H. Ling, X. Ang et al. ,"A novel shogaol analog suppresses cancer cell invasion and inflammation, and displays cytoprotective effects through modulation of NF-kappaB and Nrf2-Keap1 signaling pathways, "Toxicology and Applied Pharmacology, vol. 272, no. 3, pp. 852-862, 2013
164. R. Hu, C. L.-L. Saw, R. Yu, and A.-N. T. Kong,"Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory, "Antioxidants and Redox Signaling, vol. 13, no. 11, pp. 1679-1698, 2010
165. C. Li, X. Xu, X. J. Wang, and Y. Pan,"Imine resveratrol analogues: molecular design, Nrf2 activation and SAR analysis, "PLoS ONE, vol. 9, no. 7, Article ID e101455, 2014
166. C. R. Zhao, Z. H. Gao, and X. J. Qu,"Nrf2-ARE signaling pathway and natural products for cancer chemoprevention, "Cancer Epidemiology, vol. 34, no. 5, pp. 523-533, 2010
167. J.-S. Lee and Y.-J. Surh,"Nrf2 as a novel molecular target for chemoprevention, "Cancer Letters, vol. 224, no. 2, pp. 171-184, 2005
168. W.-S. Jeong, M. Jun, and A.-N. T. Kong,"Nrf2: a potential molecular target for cancer chemoprevention by natural compounds, "Antioxidants &Redox Signaling, vol. 8, no. 1-2, pp. 99-106, 2006
169. A. Lau, N. F. Villeneuve, Z. Sun, P. K. Wong, and D. D. Zhang,"Dual roles ofNrf2 in cancer, "Pharmacological Research, vol. 58, no. 5-6, pp. 262-270, 2008
170. T. W. Kensler, J.-G. Chen, P. A. Egner et al. ,"Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo Township, Qidong, People's Republic of China, "Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 11, pp. 2605-2613, 2005
171. F. Shang, L. Hui, X. An, X. Zhang, S. Guo, and Z. Kui,"ZnPPIX inhibits peritoneal metastasis of gastric cancer via its antiangiogenic activity, "Biomedicine &Pharmacotherapy, vol. 71, pp. 240-246, 2015
172. S. K. Sahoo, T. Sawa, J. Fang et al. ,"Pegylated zinc protoporphyrin: a water-soluble heme oxygenase inhibitor with tumortargeting capacity, "Bioconjugate Chemistry, vol. 13, no. 5, pp. 1031-1038, 2002
173. A. K. Iyer, K. Greish, T. Seki et al. ,"Polymeric micelles of zinc protoporphyrin for tumor targeted delivery based on EPR effect and singlet oxygen generation, "Journal of Drug Targeting, vol. 15, no. 7-8, pp. 496-506, 2007
174. A. Jozkowicz and J. Dulak,"Effects of protoporphyrins on production of nitric oxide and expression of vascular endothelial growth factor in vascular smooth muscle cells and macrophages, "Acta Biochimica Polonica, vol. 50, no. 1, pp. 69-79, 2003
175. A. Loboda, A. Jazwa, B. Wegiel, A. Jozkowicz, and J. Dulak,"Heme oxygenase-1-dependent and-independent regulation of angiogenic genes expression: effect of cobalt protoporphyrin and cobalt chloride on VEGF and IL-8 synthesis in human microvascular endothelial cells, "Cellular andMolecular Biology, vol. 51, no. 4, pp. 347-355, 2005
176. J. Busserolles, J. Megas, M. C. Terencio, and M. J. Alcaraz,"Heme oxygenase-1 inhibits apoptosis in Caco-2 cells via activation of Akt pathway, "International Journal of Biochemistry and Cell Biology, vol. 38, no. 9, pp. 1510-1517, 2006
177. J. Fang, T. Sawa, T. Akaike et al. ,"In vivo antitumor activity of pegylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor, "Cancer Research, vol. 63, no. 13, pp. 3567-3574, 2003
178. D. Ren, N. F. Villeneuve, T. Jiang et al. ,"Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism, "Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 4, pp. 1433-1438, 2011
179. A. Olayanju, I. M. Copple, H. K. Bryan et al. ,"Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2, "Free Radical Biology and Medicine, vol. 78, pp. 202-212, 2015
180. T. Zhang, Y. Kimura, S. Jiang, K. Harada, Y. Yamashita, andH. Ashida,"Luteolin modulates expression of drug-metabolizing enzymes through the AhR and Nrf2 pathways in hepatic cells, "Archives of Biochemistry and Biophysics, vol. 557, pp. 36-46, 2014
181. X. Tang, H. Wang, L. Fanet al. ,"Luteolin inhibitsNrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs, "Free Radical Biology andMedicine, vol. 50, no. 11, pp. 1599-1609, 2011
182. S. Chian, Y.-Y. Li, X.-J. Wang, and X.-W. Tang,"Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the Nrf2 pathway, "Asian Pacific Journal of Cancer Prevention, vol. 15, no. 6, pp. 2911-2916, 2014
183. S. Chian, R. Thapa, Z. Chi, X. J. Wang, and X. Tang,"Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo, "Biochemical and Biophysical Research Communications, vol. 447, no. 4, pp. 602-608, 2014
184. S. Magesh, Y. Chen, and L. Hu,"Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents, "Medicinal Research Reviews, vol. 32, no. 4, pp. 687-726, 2012
185. X. J. Wang, J. D. Hayes, C. J. Henderson, and C. R. Wolf,"Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha, "Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 49, pp. 19589-19594, 2007
186. M. Valenzuela, C. Glorieux, J. Stockis et al. ,"Retinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cells, "British Journal of Cancer, vol. 111, no. 5, pp. 874-882, 2014
187. N. Sadeghi, J. L. Abbruzzese, S.-C. J. Yeung, M. Hassan, and D. Li,"Metformin use is associated with better survival of diabetic patients with pancreatic cancer, "Clinical Cancer Research, vol. 18, no. 10, pp. 2905-2912, 2012
188. A. K. MacLeod, M. Mcmahon, S. M. Plummer et al. ,"Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds, "Carcinogenesis, vol. 30, no. 9, pp. 1571-1580, 2009
189. K.-A. Jung, B.-H. Choi, C.-W. Namet al. ,"Identification of aldoketo reductases as NRF2-target marker genes in human cells, "Toxicology Letters, vol. 218, no. 1, pp. 39-49, 2013
190. A. S. Agyeman, R. Chaerkady, P. G. Shawet al. ,"Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphanetreated human breast epithelial cells reveals common expression profiles, "Breast Cancer Research and Treatment, vol. 132, no. 1, pp. 175-187, 2012
191. J. Paek, J. Y. Lo, S. D. Narasimhan et al. ,"Mitochondrial SKN-1/Nrfmediates a conserved starvation response, "CellMetabolism, vol. 16, no. 4, pp. 526-537, 2012
192. S. A. Chanas, Q. Jiang, M. McMahon et al. ,"Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice, "Biochemical Journal, vol. 365, no. 2, pp. 405-416, 2002
193. J. M. Maher, M. Z. Dieter, L. M. Aleksunes et al. ,"Oxidative and electrophilic stress inducesmultidrug resistance-Associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway, "Hepatology, vol. 46, no. 5, pp. 1597-1610, 2007
194. M. S. Yates, Q. T. Tran, P. M. Dolan et al. ,"Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice, "Carcinogenesis, vol. 30, no. 6, pp. 1024-1031, 2009.